Hang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hang Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fan Fei
School of Medicine, Guizhou University, Guiyang, China
1 shared publication - Jie Ding
College of Food Science, Sichuan Agricultural University, Yaan 625014, China
1 shared publication - Junhao Chen
Saint Louis University, St. Louis, MO, USA
1 shared publication - Rui Huang
Department of Radiation Oncology Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu China
1 shared publication - Rui Mi
Key Laboratory of Germplasm Improvement and Fine Seed Breeding for Marine Aquatic Animals, Liaoning Ocean and Fisheries Science Research Institute, Dalian 116023, China
1 shared publication - Xian Li
College of Agriculture & Biotechnology, Zhejiang University, Hangzhou, 310058, China; Zhejiang Key Laboratory of Horticultural Crop Quality Improvement, Zhejiang University, Hangzhou, 310058, China
1 shared publication
Latest Publications
- Open Access
- 11 January 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1099892
The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.
- 11 January 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1099892
Open AccessThe role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.